Protalix BioTherapeutics
PLX
#8601
Rank
C$0.35 B
Marketcap
C$4.16
Share price
-5.23%
Change (1 day)
68.53%
Change (1 year)

Protalix BioTherapeutics (PLX) Fails to deliver data

Key failure to deliver metrics for Protalix BioTherapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Protalix BioTherapeutics (PLX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Protalix BioTherapeutics (PLX) - since 2019

Volume in USD (price x number of shares), data since 2019

Protalix BioTherapeutics (PLX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026C$0.69 M-56.03%
2025C$1.58 M29.54%
2024C$1.22 M-95.97%
2023C$30.31 M358.42%
2022C$6.61 M-60.58%
2021C$16.77 M183.11%
2020C$5.92 M3493.03%
2019C$0.16 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
C$34.29 MC$0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$5.05 MC$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
N/AC$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$6.55 MC$74.32 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel